Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Strum

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of the Arkansas Medical Society|December 29, 2004
Warfarin drug interactionsValerie Smith, Matthew Strum, Eugene Smith
Future Cardiology|June 3, 2025
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologistsLei Lv, Ty J Gluckman, Matthew Strum, et al.
Journal of Pharmacology & Pharmacotherapeutics|October 31, 2017
Sodium Glucose Transporter 2 Inhibitors and Diabetic Ketoacidosis in Three Patients with Diabetes: Underlying CausationJordan L Kelley, Matthew Strum, Daniel M Riche, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of the Arkansas Medical Society|December 29, 2004
Warfarin drug interactionsValerie Smith, Matthew Strum, Eugene Smith
Future Cardiology|June 3, 2025
Perceptions of high-sensitivity C-reactive protein testing (hsCRP) in atherosclerotic cardiovascular disease: a US survey on cardiologists and nephrologistsLei Lv, Ty J Gluckman, Matthew Strum, et al.
Journal of Pharmacology & Pharmacotherapeutics|October 31, 2017
Sodium Glucose Transporter 2 Inhibitors and Diabetic Ketoacidosis in Three Patients with Diabetes: Underlying CausationJordan L Kelley, Matthew Strum, Daniel M Riche, et al.
Pageof 1